Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 319-325 , April 2010

Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery

  • Jiucheng He
    • ,
  • Haydee E.P. Bazan

      Affiliations

    • Corresponding Author InformationCorrespondence to: LSU Health Sciences Center, 2020 Gravier Street, Suite D, New Orleans, LA 70112, USA. Tel.: +15045990877; fax: +15045685801.

References 

  1. Ottino P, He J, Axelrad TW, Bazan HE. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest. Ophthalmol. Vis. Sci. 2005;46:487–496
  2. He J, Bazan HE. Synergistic effect of platelet-activating factor and tumor necrosis factor-α on corneal myofibroblast apoptosis. Invest. Ophthalmol. Vis. Sci. 2006;47:883–891
  3. He J, Bazan HE. Epidermal growth factor (EGF) synergism with TGF-β1 via PI-3 kinase activity in corneal keratocyte differentiation. Invest. Ophthalmol. Vis. Sci. 2008;49:2936–2945
  4. Esquenazi S, He J, Bazan NG, Bazan HE. Comparison of corneal wound healing response in PRK and LASEK. J. Cataract Refract. Surg. 2005;31:1632–1639
  5. He J, Bazan NG, Bazan HE. Alkali-induced corneal stromal melting prevention by a novel platalet activating factor (PAF) receptor antagonist. Arch. Ophthalmol. 2006;124:70–78
  6. A.H. Kakazu, J. He, N.G. Bazan, H.E. Bazan, Aspirin-triggered lipoxin-A4 (epi-LxA4) is an important mediator for maintaining the integrity of human Corneal Endothelial cells, ARVO, E-abstract, (2009) 1818–A486.
  7. Joyce NC, Harris DL, Zieske JD. Mitotic inhibition of corneal endothelium in neonatal rats. Invest. Ophthalmol. Vis. Sci. 1998;39:2572–2583
  8. Butovich IA. Cholesteryl esters as a depot for very long chain fatty acids in human meibum. J. Lipid Res. 2009;50:501–513
  9. Holly FJ, Lemp MA. Tear physiology and dry eye. Surv. Ophthalmol. 1977;22:69–87
  10. van Setten G, Schultz G. Transforming growth factor-alpha is a constant component of human tear fluid. Graefes Arch. Clin. Exp. Ophthalmol. 1994;232:523–526
  11. Afonso A, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest. Ophthalmol. Vis. Sci. 1999;40:2506–2512
  12. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. 2001;42:2283–2292
  13. Lemp AM, The Definition and Classification Subcommittee of the International Dry Eye Workshop (2007) . The definition and classification of dry eye disease: report of the definition and classification subcommitte of the international dry eye workshop (2007). Ocul. Surf. 2007;5:75–92
  14. Smith JA, The Epidemiology Subcommittee of the International Dry Eye Workshop (2007) . The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007). Ocul. Surf. 2007;5:93–107
  15. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am. J. Clin. Nutr. 2005;82:887–893
  16. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch. Ophthalmol. 2008;126:219–225
  17. Viau S, Maire MA, Pasquis B, et al. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch. Clin. Exp. Ophthalmol. 2009;247:1039–1050
  18. Serhan CN, Hong S, Gronert K, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002;196:1025–1037
  19. Arita M, Yoshida M, Hong S, et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA. 2005;102:7671–7676
  20. Butovich IA. On the structure and synthesis of neuroprotectin D1, a novel anti-inflammatory compound of the docosahexaenoic acid family. J. Lipid Res. 2005;46:2311–2314
  21. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA. 2004;101:8491–8496
  22. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca. Curr. Eye Res. 1999;19:201–211
  23. Lobefalo L, D’Antonio E, Colangelo L, et al. Dry eye in allergic conjunctivitis: role of inflammatory infiltrate. Int. J. Immunopathol. Pharmacol. 1999;12:133–137
  24. N. Li, J. He, H.E.P. Bazan, The resolvin E1 analogs, RX-10065 and RX-10005, improve tear production and decrease inflammation in a mouse dry eye model, ARVO, E-abstract (2008).
  25. Zander E, Weddell G. Observations on the innervation of the cornea. J. Anat. 1951;85:68–99
  26. Müller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, content and function. Exp. Eye Res. 2003;76:521–542
  27. J. He, N.G. Bazan, H.E.P. Bazan, Mapping the Whole Human Corneal Nerve Architecture, ARVO, E-abstract, (2009) 2603-D1023.
  28. Linna TU, Vesaluoma MH, Perez-Santonja JJ, et al. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Invest. Ophthalmol. Vis. Sci. 2000;41:393–397
  29. Albietz JM, Lenton LM, McLennan SG. Effect of Laser in situ keratomileusis for hypopia on tear film and ocular surface. J. Cataract Refract. Surg. 2002;18:113–123
  30. Yu EY, Leung A, Rao S, Lam DS. Effect of laser in situ keratomileusis on tear stability. Ophthalmology. 2000;107:2131–2135
  31. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J. Cataract Refract. Surg. 2001;27:577–584
  32. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp. Eye Res. 2004;78:409–416
  33. Linna T, Tervo T. Realtime confocal microscopic observations on human corneal nerves and wound healing after excimer laser photorefractive keratectomy. Curr. Eye Res. 1997;16:640–649
  34. Corbett MC, Prydal JI, Verma S, Oliver KM, Pande M, Marshall J. An in vivo investigation of the structures responsible for corneal haze after photorefractive keratectomy and their effect on visual function. Ophthalmology. 1996;103:1366–1380
  35. Kauffmann T, Bodanowitz S, Hesse L, Kroll P. Corneal reinnervation after photorefractive keratectomy and laser in situ keratomileusis: an in vivo study with a confocal videomicroscope. Ger. J. Ophthalmol. 1996;5:508–512
  36. Moilanen JA, Vesaluoma MH, Muller LJ, Tervo TM. Long term corneal morphology after PRK by in vivo confocal microscopy. Invest. Ophthalmol. Vis. Sci. 2003;44:1064–1069
  37. Erie JC, McLaren JW, Hodge DO, Bourne WM. Recovery of corneal subbasal nerve density after PRK and LASIK. Am. J. Ophthalmol. 2005;140:1059–1064
  38. Chan KY, Haschke RH. Action of a trophic factor(s) from rabbit corneal epithelial culture on dissociated trigeminal neurons. J. Neurosci. 1981;1:1155–1162
  39. Chan KY, Haschke RH. Isolation and culture of corneal cells and their interactions with dissociated trigeminal neurons. Exp. Eye Res. 1982;35:137–156
  40. Emoto I, Beuerman RW. Stimulation of neurite growth by epithelial implants into corneal stroma. Neurosci. Lett. 1987;23:140–144
  41. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1997;237:1154–1162
  42. Riaz SS, Tomlinson DR. Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog. Neurobiol. 1996;49:125–143
  43. Mearow KM, Dril Y, Diamond J. Increased NGF mRNA expression in denervated rat skin. Neuroreport. 1993;4:351–354
  44. Verge VM, Merlio JP, Grondin J, et al. Colocalization of NGF binding sites, trk mRNA, and low affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J. Neurosci. 1992;12:4011–4022
  45. Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest. Ophthalmol. Vis. Sci. 2000;41:1063–1069
  46. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med. 1998;338:1174–1180
  47. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107:1347–1351
  48. Joo MJ, Yuhan KR, Hyon JY, et al. The effect of nerve growth factor on corneal sensitivity after laser in situ keratomileusis. Arch. Ophthalmol. 2004;122:1338–1341
  49. Esquenazi S, Bazan HE, Bui V, He J, Kim DB, Bazan NG. Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 2005;46:3121–3127
  50. Bazan NG, Rodriguez de Turco EB. Review: pharmacological manipulation of docosahexaenoic-phospholipid biosynthesis in photoreceptor cells: implications in retinal degeneration. J. Ocul. Pharmacol. 1994;10:591–604
  51. Bazan NG. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 buisynthesized from docosahexaenoic acid: the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 2007;48:4866–4881
  52. Mukherjee PK, Marcheselli VL, Barreiro S, Hu J, Bok D, Bazan NG. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc. Natl. Acad. Sci. USA. 2007;104:13152–13157
  53. Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docosanoids inhibit brain ischemia reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 2003;278:43807–43817
  54. Tombran-Tink J, Barnstable. CJ, PEDF A. Multifaceted neurotrophic factor. Nat. Rev. Neurosci. 2003;4:628–636
  55. Becerra SP. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp. Eye Res. 2006;82:739–749
  56. Houenou LJ, D'Costa AP, Li L, et al. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol. 1999;412:506–514
  57. M.S. Cortina, J. He, N. Li, N.G. Bazan, H.E. Bazan, PEDF plus DHA induces neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery, Invest. Ophthalmol. Vis. Sci. 51 (2010) 804–810.
  58. Bazan HE, Bazan NG. Composition of phospholipids and free fatty acids and incorporation of labeled arachidonic acid in rabbit cornea. Comparison of epithelium, stroma and endothelium. Curr. Eye Res. 1984;3:1313–1319

☆ The authors’ work described here was supported by National Institutes of Health, National Eye Institute grant R01 EY19465, by a Translational Research Initiative grant from the Lousiana State University Health Sciences Center, New Orleans, and by a grant from Resolvyx Pharmaceuticals, Bedford, Massachusetts.

PII: S0952-3278(10)00048-7

doi: 10.1016/j.plefa.2010.02.004

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 319-325 , April 2010

Article Tools

* Image Usage & Resolution